Cheri W Fink

Title: Cheri W. Fink: Innovator in Enzyme Assays

Introduction

Cheri W. Fink, hailing from Prairie, Minnesota, is an accomplished inventor recognized for her contributions to enzyme assays. With a focus on improving the accuracy of clinical tests, her innovative methods are paving the way for advancements in medical diagnostics.

Latest Patents

Cheri holds a patent for a groundbreaking method titled "Method of Pre-Treating Samples in Peroxidase-Catalyzed Enzyme Assays." This patent introduces an effective approach to mitigate the occurrence of falsely elevated results caused by blood or blood products in clinical specimens. By reacting the specimen with an oxidizing agent such as sodium hypochlorite, hydrogen peroxide, or sodium meta-periodate, her method significantly reduces interference in enzyme assays.

Career Highlights

Cheri is a key contributor at Kallestad Diagnostics, Inc., where she applies her expertise to develop innovative solutions in the field of diagnostics. Her work is instrumental in enhancing the reliability of test results, thereby improving patient care outcomes.

Collaborations

Throughout her career, Cheri has collaborated with notable colleagues, including Patrick A. Mach and Jeffrey A. Thompson. Together, they have worked on various initiatives to drive innovation within the field, sharing insights and expertise to foster advancements in enzyme assay methodologies.

Conclusion

Cheri W. Fink's dedication to innovation in enzyme assays exemplifies the vital role of inventors in advancing medical diagnostics. With her valuable patent and contributions to Kallestad Diagnostics, she stands as a prominent figure in the field, continually working towards greater accuracy and reliability in clinical testing.